Considering that SCRIB-P305L mutant interacts with LLGL2 (Fig. 2h), SCRIB works as a scaffold of SLC7A5-SLC3A2 complex to direct the membrane localization of SLC3A2 in ER+ breast cancer cells. Here, LLGL2 is linked to breast carcinoma.